Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/09/2014 | US20140303403 Chemically modified small molecules |
10/09/2014 | US20140303329 Method of manufacturing a pharmaceutical composition having chelating type complex micelles |
10/09/2014 | US20140303264 Process for Making and Using Cellulose-Containing Seaweed Residue and Products Made Therefrom |
10/09/2014 | US20140303261 Adhesive Composition |
10/09/2014 | US20140303258 Method of solubilizing insoluble bioactive compounds using triterpene glycosides and compositions thereof |
10/09/2014 | US20140303250 Pharmaceutical Solid Compositions Containing Ibuprofen Salts |
10/09/2014 | US20140303245 Sustained Release Composition of Prostacyclin |
10/09/2014 | US20140303232 Lipids and lipid compositions for the delivery of active agents |
10/09/2014 | US20140303225 Pharmaceutical composition for peroral administration of 3,3'-diindolylmethane |
10/09/2014 | US20140303219 Ocular Formulations for Drug-Delivery to the Posterior Segment of the Eye |
10/09/2014 | US20140303215 Topically applicable pharmaceutical preparation |
10/09/2014 | US20140303214 Transmucosal drug delivery system |
10/09/2014 | US20140303211 Compositions containing opioid antagonists |
10/09/2014 | US20140303183 Solution for oral administration |
10/09/2014 | US20140303145 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer |
10/09/2014 | US20140303107 Drug formulations |
10/09/2014 | US20140303084 Pro-Coagulant Compounds and Methods of Use Thereof |
10/09/2014 | US20140303081 Apoptosis-targeting nanoparticles |
10/09/2014 | US20140303077 Albumin fusion proteins |
10/09/2014 | US20140303022 Magnetic-nanoparticle conjugates and methods of use |
10/09/2014 | US20140302213 Method for manufacturing pure guar flour |
10/09/2014 | US20140302157 Nanoparticle formulations and uses therof |
10/09/2014 | US20140302151 Methods and compositions for treating pain |
10/09/2014 | US20140302144 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies |
10/09/2014 | US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions |
10/09/2014 | US20140302142 Compositions and methds for enhancing penetration of biologically active substances into tissues or organs |
10/09/2014 | US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions |
10/09/2014 | US20140302132 Pharmaceutical composition comprising nanocrystals |
10/09/2014 | US20140302129 Human lubrication gel |
10/09/2014 | US20140302126 Rhein or diacerein compositions |
10/09/2014 | US20140302121 Cannabinoid Receptor Binding Agents, Compositions and Methods |
10/09/2014 | US20140302120 Conjugates of synthetic tlr agonists and uses therefor |
10/09/2014 | US20140302118 Hydrous adhesive skin patch |
10/09/2014 | US20140302115 Drug delivery system based on polyethylene vinylacetate copolymers |
10/09/2014 | US20140302110 Magnetic field-controlled movable bio-scaffold and constructing method thereof |
10/09/2014 | US20140302104 Conjugated polymeric material and uses thereof |
10/09/2014 | US20140302099 Ophthalmic Composition Containing Cyclosporine And method For Preparing Same |
10/09/2014 | US20140302098 Yeast-based vaccines as immunotherapy |
10/09/2014 | US20140302091 Methods and compositions for live attenuated viruses |
10/09/2014 | US20140302084 Immunogenic protein conjugates and method for making and using the same |
10/09/2014 | US20140302066 Pyrrolobenzodiazepines and targeted conjugates |
10/09/2014 | US20140302055 Antibodies Directed to Angiopoietin-like Protein 4 and Uses Thereof |
10/09/2014 | US20140302043 Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
10/09/2014 | US20140302034 Novel modulators and methods of use |
10/09/2014 | US20140302008 Stable formulations of botulinum toxin in hydrogels |
10/09/2014 | US20140302007 Botulinum toxin formulation |
10/09/2014 | US20140302001 Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases |
10/09/2014 | US20140301998 Preparation containing diol |
10/09/2014 | US20140301970 Vitamin functionalized gel-forming block copolymers for biomedical applications |
10/09/2014 | US20140301969 Metap-2 inhibitor polymersomes for therapeutic administration |
10/09/2014 | US20140301946 Antibody drug conjugates |
10/09/2014 | US20140301945 Human anti-sod1 antibodies |
10/09/2014 | DE112013000636T5 Stabile Kolloidale Suspensionen aus Goldnanokonjugaten und das Verfahren zur Zubereitung derselben Stable colloidal suspensions of Goldnanokonjugaten and the method for preparation thereof |
10/08/2014 | EP2787072A1 A method of production of a stable composite of bacterial bionanocellulose with perforated metal or polymeric material, designed for tissues reconstruction |
10/08/2014 | EP2787051A1 Cooling agent and trpm8 activator |
10/08/2014 | EP2787050A1 Lecithin-organogel-forming agent |
10/08/2014 | EP2786766A1 Supramolecular aggregates comprising maleimido cores |
10/08/2014 | EP2786752A1 Ropinirole-containing adhesive patch |
10/08/2014 | EP2786746A1 Stabilizing a Liquid Formulation Containing a Protein Drug |
10/08/2014 | EP2786737A1 Reducing agent containing sodium borohydride |
10/08/2014 | EP2785838A2 Targeted lysosomal enzyme compounds |
10/08/2014 | EP2785837A2 Targeted enzyme compounds and uses thereof |
10/08/2014 | EP2785635A1 Mmp-targeted therapeutic and/or diagnostic nanocarriers |
10/08/2014 | EP2785379A1 Peptide-mediated delivery of active agents across the blood-brain barrier |
10/08/2014 | EP2785364A1 Use of p3 of bacteriophage as amyloid binding agents |
10/08/2014 | EP2785333A1 Amphipathic lipid-based sustained release compositions |
10/08/2014 | EP2785328A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine |
10/08/2014 | EP2785327A1 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same |
10/07/2014 | US8853451 Processes for making hydrazides |
10/07/2014 | US8853423 Indane estrogen receptor modulators and uses thereof |
10/07/2014 | US8853354 Polyion complex comprising hydrophobized polyamino acid and use of the same |
10/07/2014 | US8853325 Water-soluble polymer alkanals |
10/07/2014 | US8853283 Stable crystal modifications of DOTAP chloride |
10/07/2014 | US8853268 Ophthalmic solution |
10/07/2014 | US8853260 Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
10/07/2014 | US8853247 Oligomer-nitroimidazole anti-infective conjugates |
10/07/2014 | US8853223 Therapeutic composition to treat lesions caused by herpes simplex virus |
10/07/2014 | US8853195 Composition for reducing the exudation of serum proteins |
10/07/2014 | US8853192 Fat or oil composition |
10/07/2014 | US8853187 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
10/07/2014 | US8853184 Polysaccharide gel formulation having increased longevity |
10/07/2014 | US8853168 Compositions for the reversible thioesterification of signaling proteins and methods of using same |
10/07/2014 | US8853167 Short-chain cationic polyamino acid and use thereof |
10/07/2014 | US8853154 Fibronectin based scaffold domain proteins that bind to myostatin |
10/07/2014 | US8853151 Pro-drug complexes and related methods of use |
10/07/2014 | US8852895 Macrocyclic derivative and assemblies formed therefrom |
10/07/2014 | US8852648 Delivery of biologically-active agents using volatile, hydrophobic solvents |
10/07/2014 | US8852645 Self-assembled toroidal-spiral particles and manufacture and uses thereof |
10/07/2014 | US8852640 Micelles for delivery of nitric oxide |
10/07/2014 | US8852638 Sustained release small molecule drug formulation |
10/07/2014 | US8852629 Drug delivery system for hydrophobic drugs |
10/07/2014 | US8852626 Controlled-release CNS modulating compositions and methods for the treatment of otic disorders |
10/07/2014 | US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
10/07/2014 | US8852607 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
10/07/2014 | US8852606 Capsular polysaccharide solubilisation and combination vaccines |
10/07/2014 | US8852605 Vibrio cholerae O139 conjugate vaccines |
10/07/2014 | US8852603 Inhibition of secretion from non-neuronal cells |
10/07/2014 | US8852599 Immunoconjugates, compositions for making them, and methods of making and use |
10/07/2014 | US8852566 Compositions and methods for preferential distribution of active agents to injury sites |
10/07/2014 | US8852561 Fluoride varnish compositions including an organo phosphoric acid adhesion promoting agent |